India’s biopharma and biomedical industry is valued at over $58 billion. The new technology could help ensure that the ...

Dublin, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The "Strategic Intelligence: The State of the Biopharmaceutical Industry 2025" report has been added to ResearchAndMarkets.com's offering. The research report ...

Forte Biosciences, which researches treatments for autoimmune diseases like celiac disease and vitiligo, will be bought by ...

Sichuan Kelun-Biotech Biopharmaceutical stock has delivered a very large 3 year gain, yet current valuation checks and market ...

With biosimilars being an everyday headline, Jason Bernstein, Epocrates Lead Strategist, outlined key reasons for pharma's growing interest in biosimilar development and key differences between ...

Modern technologies, including Industry 4.0 and the Industrial Internet of Things, offer opportunities to increase biopharmaceutical manufacturing efficiency. Biopharmaceutical manufacturing companies ...

By Lucie Barbier and Margaux Perrin July 30 (Reuters) - Belgian biopharmaceutical group UCB raised its 2026 earnings guidance ...

Hong Kong-listed Sino Biopharmaceutical said on Wednesday it ​has granted AstraZeneca the ‌rights to develop a drug designed to treat chronic respiratory ​diseases outside China for ​total payments of ...

Pfizer announced it will invest $465 million to build a new Modular Aseptic Processing Facility in Kalamazoo County, MI. The 400,000-square-foot facility, which will produce critical life-saving ...

The biopharmaceutical industry in America not only contributes to the better health of people all over the world, it also generates economic value for local communities in states all across our ...

DesigneRx Pharmaceuticals is shuttering the largest of its two Vacaville facilities after 24 years in the city. Does this and ...

“U.S. policymakers misled by patent myths and manipulated data seem to be ignoring the economic and technological realities of biopharmaceutical innovation.” The following is condensed from an Issue ...